JO2129B1 - Non Aqueous anthelmintic composition - Google Patents
Non Aqueous anthelmintic compositionInfo
- Publication number
- JO2129B1 JO2129B1 JO19992129A JOP19992129A JO2129B1 JO 2129 B1 JO2129 B1 JO 2129B1 JO 19992129 A JO19992129 A JO 19992129A JO P19992129 A JOP19992129 A JO P19992129A JO 2129 B1 JO2129 B1 JO 2129B1
- Authority
- JO
- Jordan
- Prior art keywords
- non aqueous
- anthelmintic composition
- composition
- anthelmintic
- milb
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Abstract
A veterinary composition, for combating endoparasites and ectoparasites, and offering an improved pharmacokinetic profile, contains as parasiticide an Avermectin, especially Ivermectin or a Milb emycin, in an amount of from about 0.1 %w/v to 20 %w/v, dissolved in a solvent system containing up to about 75 %v/v of polyethylene glycol and not less than about 25 %v/v glycerol formal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9816132.6A GB9816132D0 (en) | 1998-07-24 | 1998-07-24 | Non-aqueous anthelmintic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JO2129B1 true JO2129B1 (en) | 2002-08-07 |
Family
ID=10836088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JO19992129A JO2129B1 (en) | 1998-07-24 | 1999-07-20 | Non Aqueous anthelmintic composition |
Country Status (9)
Country | Link |
---|---|
AR (1) | AR020613A1 (en) |
AU (1) | AU5054099A (en) |
CO (1) | CO5070578A1 (en) |
DZ (1) | DZ2853A1 (en) |
GB (2) | GB9816132D0 (en) |
JO (1) | JO2129B1 (en) |
PE (1) | PE20001064A1 (en) |
UY (1) | UY25622A1 (en) |
WO (1) | WO2000004906A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001020994A1 (en) * | 1999-09-22 | 2001-03-29 | Ashmont Holdings Limited | Sheep pour-on |
AUPR602501A0 (en) * | 2001-06-29 | 2001-07-26 | Smart Drug Systems Inc | Sustained release pharmaceutical composition |
AUPR610501A0 (en) * | 2001-07-04 | 2001-07-26 | Smart Drug Systems Inc | Treatment of parasitic disease |
GB0316377D0 (en) * | 2003-07-12 | 2003-08-13 | Norbrook Lab Ltd | Parasiticidal composition |
CN115399316A (en) * | 2022-09-15 | 2022-11-29 | 湖北省农业科学院植保土肥研究所 | Pesticide tank-mixed auxiliary composition and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ210505A (en) * | 1983-12-22 | 1988-06-30 | Merck & Co Inc | Parasiticidal compositions containing avermectin or milbemycin derivatives |
NZ248486A (en) * | 1993-08-24 | 1996-07-26 | Ashmont Holdings Limited Subst | Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent |
AUPM969994A0 (en) * | 1994-11-28 | 1994-12-22 | Virbac S.A. | Equine anthelmintic formulations |
ZA979483B (en) * | 1996-10-25 | 1998-05-20 | Chemvet Nz Ltd | Anthelmintic formulation. |
-
1998
- 1998-07-24 GB GBGB9816132.6A patent/GB9816132D0/en not_active Ceased
-
1999
- 1999-07-03 GB GB9915531A patent/GB2339691A/en not_active Withdrawn
- 1999-07-20 JO JO19992129A patent/JO2129B1/en active
- 1999-07-21 DZ DZ990153A patent/DZ2853A1/en active
- 1999-07-21 AU AU50540/99A patent/AU5054099A/en not_active Abandoned
- 1999-07-21 WO PCT/GB1999/002364 patent/WO2000004906A1/en active Application Filing
- 1999-07-21 AR ARP990103572A patent/AR020613A1/en unknown
- 1999-07-22 PE PE1999000735A patent/PE20001064A1/en not_active Application Discontinuation
- 1999-07-22 CO CO99046067A patent/CO5070578A1/en unknown
- 1999-07-23 UY UY25622A patent/UY25622A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE20001064A1 (en) | 2000-10-11 |
CO5070578A1 (en) | 2001-08-28 |
UY25622A1 (en) | 2000-02-23 |
AR020613A1 (en) | 2002-05-22 |
WO2000004906A1 (en) | 2000-02-03 |
GB9816132D0 (en) | 1998-09-23 |
AU5054099A (en) | 2000-02-14 |
GB2339691A (en) | 2000-02-09 |
GB9915531D0 (en) | 1999-09-01 |
DZ2853A1 (en) | 2003-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY25806A1 (en) | ANTIPARASITIC FORMULATIONS CONTAINING AVERMECTINS OR MILBEMICINES. | |
MXPA05010659A (en) | Topical anthelmintic veterinary formulations. | |
AR021539A1 (en) | TOPIC ANHYDRING PREPARATIONS FOR SKIN | |
DK0971705T3 (en) | Hormone replacement therapy drug formulations for topical application to the skin | |
WO2005062782A3 (en) | Non-animal product containing veterinary formulations | |
BR0008590A (en) | Polymeric delivery agent, composition, unit dosage form, method for administering a biologically active agent to an animal requiring the agent, method for preparing a composition; it's composed | |
BR9909796B1 (en) | "PIPERIDINOPYRIMIDINE DERIVATIVES FOR TOPICAL APPLICATION" | |
MX9703429A (en) | Hemorrhoidal compositions and method of use. | |
TR199802700T2 (en) | Ha�ere �ld�r�c� bile�imler. | |
TW565461B (en) | Immunosuppressive pharmaceutical composition for external application | |
NZ210505A (en) | Parasiticidal compositions containing avermectin or milbemycin derivatives | |
AR021370A1 (en) | STABILIZED INJECTABLE PHARMACEUTICAL COMPOSITIONS CONTAINING TAXOID ANTI-NEOPLASIC AGENTS | |
DE69920201D1 (en) | COMPOSITIONS CONTAINING GLYCOLE DERIVATIVES, ALCOHOLS AND VITAMIN D | |
DE69526970D1 (en) | STABILIZED SOLUTIONS CONTAINING 2-CHLORO-2'-DEOXYADENOSINE | |
GB2329585A (en) | A barrier cream comprising hexamethylenetetramine or derivative thereo | |
JO2129B1 (en) | Non Aqueous anthelmintic composition | |
IL131128A0 (en) | Nimesulide gel systems for topical use | |
GB9801109D0 (en) | Cyclodextrin compositions | |
HUP0203847A3 (en) | Substituted homopiperidinyl benzimidazole analogues as fundic relaxants, process for their preparation and pharmaceutical compositions containing them | |
ATE223221T1 (en) | SOLUBLE MEDICINAL COMPOSITIONS CONTAINING 2-CHLORO-2'-DEOXYADENOSINE | |
ATE289609T1 (en) | MACROLIDE LHRH ANTAGONISTS | |
NZ506622A (en) | 3',3'-N-bis-substituted macrolide LHRH antagonists | |
WO2000058328A3 (en) | Avermectin derivatives | |
WO2003040316A3 (en) | Selective elimination of cd52+ cells and uses thereof | |
BR0303489A (en) | Stabilized pharmaceutical composition of fluorine ether compound and method for inhibiting the degradation of fluorine ether compound. use of stabilizing agent to inhibit the degradation of fluorine ether compound |